Allianz Asset Management’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
Other funds holding CCXI
Allianz Asset Management's CCXI Position: Q4 2022 in Review
Allianz Asset Management sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 541,480 shares — an estimated $28M sold.
Allianz Asset Management first reported a position in CCXI in Q4 2019 and held it in 12 quarters. The position peaked at $28M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.
- Allianz Asset Management reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
- Allianz Asset Management sold 541,480 ChemoCentryx, Inc. shares in Q4 2022, an estimated $28M.
- Allianz Asset Management first reported a position in ChemoCentryx, Inc. in Q4 2019 and held it in 12 quarters.
- Allianz Asset Management's ChemoCentryx, Inc. position peaked at $28M in Q3 2022.
- 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.
Based on Allianz Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.